Testing version — LOERadar is in active testing. Features and data may change.
LAMIVUDINE (LAMIVUDINE) | LOERadar
Tentative Approval — This application has been tentatively approved by the FDA but is not yet listed in the Orange Book. It is blocked from final approval by unexpired patents or exclusivities on the reference listed drug.
LAMIVUDINE
ANDATentative Approval
LAMIVUDINE | A090433 | ALKEM LABS LTD
Products (1)
#001 — 150MG
▴
TABLET; ORAL | TA Date: Mar. 16, 2009
No patent or exclusivity listings for this strength.